Of note, genomic amplification of FGF19 has previously been identified in hepatocellular carcinoma63,64 and more rarely in hepatoblastoma22, supporting the notion that FGF19 signaling can provide a growth advantage in liver cancers. The gene discussed is FGF19; the disease is liver cancer.